Emily Pimblett - Mar 18, 2024 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Brian Woodard, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
Mar 18, 2024
Transactions value $
$0
Form type
4
Date filed
3/20/2024, 04:33 PM
Previous filing
Mar 21, 2023
Next filing
Jun 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Restricted Stock Units Options Exercise $0 +40K $0.00 40K Mar 18, 2024 Common Stock 40K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.